Journal of Environmental and Public Health
Volume 2020 (2020), Article ID 2571293, 6 pages
https://doi.org/10.1155/2020/2571293

Research Article

Detection of Carbapenem-Resistant Genes in Escherichia coli Isolated from Drinking Water in Khartoum, Sudan

Neama Esmat Mahmoud,¹ Hisham N. Altayb,² and Reem Majzoub Gurashi¹

¹Department of Microbiology, Faculty of Medical Laboratories Sciences, Alneelain University, Khartoum, Sudan
²Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah 21452, Saudi Arabia

Correspondence should be addressed to Neama Esmat Mahmoud; n3oom95@gmail.com

Received 2 October 2019; Revised 16 April 2020; Accepted 28 May 2020; Published 12 June 2020

Academic Editor: Ping Xiang

Copyright © 2020 Neama Esmat Mahmoud et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Waterborne Escherichia coli are a major reservoir of antimicrobial resistance (AMR). Carbapenem-resistance, especially when mediated by transferable carbapenemase-encoding genes, is spreading worldwide and causing dramatically limiting treatment options. In our country, studies for the detection of carbapenem resistance in drinking water do not exist; therefore, this work was carried out to determine the prevalence of carbapenem-resistant genes “blaKPC, blaIMP, blaNDM, blaSPM, blaVIM, and blaOXA-48” among Escherichia coli isolated from drinking water in Khartoum, Sudan. A total of forty-five E. coli bacteria were isolated from different sources of drinking water. Antimicrobial susceptibility testing was performed using imipenem (10 mg/disc), gentamicin (10 mg/disc), ceftriaxone (30 mg/disc), ciprofloxacin (5 mg/disc), chloramphenicol (30 mg/disc), and tetracycline (30 mg/disc). “Sensitive” or “resistant” patterns of E. coli were judged using antibiotic minimum inhibitory concentration (MIC). Bacterial genomic DNA was extracted by the boiling method, and then multiplex polymerase chain reaction was performed to detect the carbapenemase genes (blaKPC, blaIMP, blaNDM, blaSPM, blaVIM, and blaOXA-48). Multiplex PCR assays confirmed the presence of carbapenemase genes in 28% of all water isolates. OXA-48 gene was the most predominant gene, detected in 15.5% of the isolates. The blaKPC and blaSPM genes were also detected in 4.4% and 8.8% of the isolates, respectively. However, the isolates were negative for blaNDM, blaVIM, and blaIMP genes. The isolates showed a high rate of tetracycline resistance (97.7%), followed by gentamicin (57.7%), ciprofloxacin (46.6%), ceftriaxone (35.5%), and chloramphenicol (31.1%). In conclusion, this study confirmed for the first time the presence of E. coli carried carbapenem-resistant genes in the drinking water of Khartoum state, Sudan. These isolates commonly carried OXA-48 (7/45), followed by SPM (4/45) and KPC (2/45).

1. Introduction

Good health depends on clean, safe water supply. However, it should be free from toxic chemical and pathogenic microorganisms [1]. The determination that water is consequently unsafe to drink is by focusing on detecting fecal contamination. High fecal levels can mean that water contains pathogens [2]. Escherichia coli are often used as an indicator of fecal contamination of drinking water, and ingestion of water contaminated with E. coli can lead to serious complications including diarrhea, enteritis, and mortality in some cases [3–5]. Antimicrobial-resistant (AMR) bacteria are widespread in environmental waters, and E. coli is a concerning reservoir for AMR due to its plenty in such environments with a high risk of transfer from the environment to humans [6–8].

Escherichia coli have become intrinsically resistant to many types of β-lactamase due to the emergence of organisms carrying extended-spectrum b-lactamases (ESBLs) and plasmid-mediated AmpC β-lactamases [9]. Carbapenems, among the beta-lactams, are the most effective agents for the treatment of severe infection caused by ESBL-positive E. coli, and their unique molecular structure is due to the presence of a carbapenem together with the beta-lactam ring [10–12]. Resistance to carbapenems occurs due to the production of carbapenemases, a class of enzymes capable of hydrolyzing carbapenems and other β-lactams; the other mechanisms can be by the poor binding of carbapenems to penicillin-binding proteins present in the bacteria, lack of porins present in the bacterial cell membrane, and overexpression of multidrug efflux pumps by the bacteria [9, 13]. They are classes of enzymes capable of hydrolyzing carbapenems and other β-lactams, including classes A, B, and D. KPCs are the most frequently encountered enzymes in class A carbapenemases. Class B metallo-β-lactamases (MBLs) are mostly of the VIM, IMP, SPM, GM, SIM, and NDM. Class D β-lactamases, also named OXAs, OXA-48, represent the main enzyme isolated around the world [14].

Klebsiella pneumoniae carbapenemase (KPC) was first identified in the USA and then continue to spread globally [14]. New Delhi metallo-beta-lactamases (NDM-1) is rapidly spread since it is detected in India and disseminated through patients traveled to many countries [14]. Imipenemase (IMP) and Verona imipenemase (VIM) type metallo-beta-lactamases (MBLs) were first identified in Japan and Italy, respectively, and have successfully spread to all continents since then. Sao Paolo metallo-β-lactamase (SPM) is more geographically restricted and remains mostly confined in South America. Oxacillinase (OXA-48) is the most prevalent in the Middle East and North Africa, as well as other countries worldwide [10, 11, 15].

The quality of drinking water has an important role in human infection and disease. Contaminated water plays an important role in the transmission of carbapenem-resistant E. coli to humans. The dissemination of the resistance gene represents a serious public health threat, which causes dangerous limitation of treatment option, and significant mortality rate [1, 2]. Our study aimed at determining the prevalence of carbapenem-resistant genes “blaKPC, blaIMP, blaNDM, blaSPM, blaVIM, and blaOXA-48” among Escherichia coli isolated from drinking water in Khartoum, Sudan.

2. Materials and Methods

2.1. Sample Collection and Isolation of E. coli

Forty-five isolates of E. coli were identified from 150 water samples in the central public health laboratory in Khartoum, Sudan, from January to June 2017. Water samples were collected from different water sources, including taps (40), cooler (40), and tanks (70) in houses. The samples were cultured in two bottles of Brilliant Green Bile Broth (BGBB) media with Durham tube and incubated for 48 hours in 37°C; after incubation, turbidity and gas represented the presence of coliform, the positive samples were purified in EMB media and MacConkey agar, and then they were identified using Gram stain and biochemical tests including Kliger iron agar, indole, citrate, and urease tests [16, 17].

2.2. Antibiotic Susceptibility Test

Forty-five isolates were screened for antimicrobial resistance using the Kirby-Bauer disc diffusion method. Six antibiotics tested included imipenem (10 mg/disc), gentamicin (10 mg/disc), ceftriaxone (30 mg/disc), ciprofloxacin (5 mg/disc), chloramphenicol (30 mg/disc), and tetracycline (30 mg/disc). “Sensitive,” “intermediate resistant,” or “resistant” patterns of E. coli were judged using antibiotic minimum inhibitory concentration (MIC) provided by the guidelines of the Clinical and Laboratory Standards Institute (CLSI). E. coli strain ATCC, no. 25922, was used as quality control. All isolates showing “resistant” or “intermediate resistant” patterns were classified as “resistant” [6, 18].

2.3. DNA Extraction

Bacterial DNA was extracted using the boiling method. Firstly, a single colony from all bacterial strains was subcultured on Muller-Hinton agar, and after overnight incubation, several colonies were emulsified in a test tube containing 1 ml of the distilled water and boiled at 95°C for 10 minutes, and then the supernatant containing DNA was transferred to a new Eppendorf tube [19].

2.4. Multiplex PCR for the Detection of Carbapenemase Genes

The presence of the carbapenemases genes was determined using gene-specific primer targeting blaNDM, blaIMP, blaVIM,blaSPM, blaKPC, and blaOXA_48. The primers were obtained from the Macrogen Company, Korea (Table 1).

Table 1: Primer sequences used in this study.

Primer name
Sequence (5′-3′)
Amplicon size (Pb)
References

blaSPM
Forward: AAAATCTGGGTACGCAAACG
Reverse: ACATTATCCGCTGGAACA
271
[20]

blaVIM
Forward: GGTGTTTGGTCGCATATCGCAA
Reverse: ATTCAGCCAGATCGGCATCGGC
502
[20]

blaIPM
Forward: TCGTTTGAAGAAGTTAACG
Reverse: ATGTAAGTTTCAAGAGTGATGC
568
[20]

blaNDM
Forward: GGTTTGGCGATCTGGTTTTC
Reverse: CGGAATGGCTCATCACGATC
624
[20]

blaKPC
Forward: CATTCAAGGGCTTTCTTGCTGC
Reverse: ACGACGGCATAGTCATTTGC
498
[21]

blaOXA-48
Forward: GCTTGATCGCCCTCGATT
Reverse: GATTTGCTCCGTGGCCGAAA
238
[21]

2.4.1. Method for Detection of blaNDM, blaIMP, blaVIM, blaSPM, blaKPC, and blaOXA_48

PCR was carried out in a total reaction volume of 20 µl consisting of 0.6 µ forward and 0.6 µ of the reverse primer for each gene, and 5 µl of extracted DNA and 8.8 µl of distilled water were added to 5 µl of PCR master mix (Maximum PCR Premix Kit i-Taq, iNtRON, Biotechnology, Korea). For blaKPC and blaOXA_48, the same volume from primers and extracted DNA was added to 8.2 of distilled water and 5 µl PCR master mix to reach the final volume of 20 µl. E. coli harbored KPC gene was used as a positive control [20].

2.4.2. PCR Amplification

The thermal cycling machine (TECHNE 412, UK) was programmed for 35 cycles for DNA amplification. The program consists of an initial denaturation step at 95°C for 5 minutes, denaturation and annealing at 94°C and 60°C, respectively, for 45 seconds, and elongation for one minute at 72°C. The same program was used for blaKPC, and blaOXA_48, except annealing temperature, was adjusted to 55°C for 45 seconds, and all primer sets had a final extension of 72°C for 7 minutes [20, 21].

2.4.3. Visualization of Genome

Gel electrophoresis was done after PCR to visualize bands. 1.5 µl from ethidium bromide was added to 2% agarose gel and poured into the casting tray for solidification, and then 5 µl from extracted DNA was placed in the wells. The voltage applied was 60 volts, and the current was adjusted to 100 Amperes for 30 minutes. After that, the PCR product was visualized using a UV transilluminator [22].

2.5. Data Analysis

The collected data were analyzed by the statistical package of social science (SPSS) program version 21.0; the chi-square test was used to assess the association between variables, and the value that considered significant was less than 0.05 [23].

3. Results

Forty-five isolates were successfully grown on BGBB media and confirmed as E. coli by the biochemical test. Twenty-eight isolates were obtained from tanks, whereas 12 and 5 isolates were collected from tap water and cooler, respectively. The result showed that there was a high frequency of E. coli isolates in tanks (28/70, 40%) and low frequency of isolates in tap water and cooler (12/40, 30%, and 5/40, 12.5%), respectively. The prevalence of E. coli in drinking water source is shown in Figure 1.

Figure 1: The prevalence of E. coli in different drinking water sources.

3.1. Susceptibility Testing

Carbapenem: the antimicrobial susceptibility pattern showed 33% (15/45) of isolates were resistant to imipenem, while 66% (30/45) were susceptible.

Other antibiotics: resistance to tetracycline (97.7%) was the highest among the antibiotics used, followed by gentamicin (57.7%), ciprofloxacin (46.6%), ceftriaxone (35.5%), and chloramphenicol (31.1%).

3.2. Detection of Carbapenem-Resistant Genes

Based on PCR assay, twenty-eight percent (13/45) of the isolates carried one carbapenem gene. Predominantly 7 isolates (15.5%) were positive for blaOXA-48, followed by blaSPM (8.8%, 4/45) and blaKPC (4.4%, 2/45), while all isolates lack the other three genes blaNDM, blaVIM, and blaIMP. PCR amplification for genes product is shown in Figure 2. The number of bacterial strains positive for carbapenem-resistant genes is illustrated in Table 2, while Table 3 and Figure 3 demonstrate the association between antibiotic resistance and the presence of carbapenem-resistant genes.

Figure 2: Multiplex PCR for amplification of blaOXA-48 and blaKPC genes on 2% agarose gel electrophoresis: lane 5: DNA ladder 100 bp; lanes 1, 2, 3, 4, 6, 7, 8, and 9 are OXA-48 positive samples showing a typical band size of (238 bp). Lane 9 is a positive sample for blaKPC showing a typical band size of (498 bp).

Table 2: The number of bacterial strains positive for carbapenem-resistant genes.

Genes
Number of bacteria strains

blaOXA-48
7

blaKPC
2

blaSPM
4

Table 3: The association between antibiotic resistance and the presence of carbapenem-resistant genes.

Genes
Imipenem
Chloramphenicol
Ceftriaxone
Gentamicin
Ciprofloxacin
Tetracycline

blaOXA-48
7
4
5
5
7
6

blaKPC
2
1
0
1
1
2

blaSPM
4
2
1
1
3
2

Figure 3: Antibiotics resistance rate among E. coli harbored carbapenem-resistant genes.

4. Discussion

Escherichia coli is one of the major etiologic agents for urinary tract infection, sepsis, enteritis, and meningitis; in addition, E. coli has a common role in contaminated drinking water that can lead to a serious complication including diarrhea and enteritis [4, 12]. Carbapenem-resistant E. coli is an important public health concern worldwide. The presence of this resistant bacteria may contribute to increasing the risk to human health. So it is important to have more information regarding such issues [16, 24, 25]. In the present study, we found that 13/15 (86%) of imipenem resistance isolates were positive for blaOXA, blaSPM, and blaKPC genes. 15.5% of isolates (7/45) harbored the blaOXA-48 gene, the most predominant gene. There was a significant association ( value = 0.003) between the presence of the blaOXA-48 gene and water sources (tap water, cooler, and tanks). This finding is in agreement with a study conducted by Amaya et al. in Nicaragua; they reported that gene encoding for blaOXA was detected in 1% of well-water samples [26]. There was another study done by Tanner et al.; they identified blaOXA-48-type genes (3.9%) in US drinking water. In contrast, the same study was not in agreement with our result. However, the blaKPC gene was not detected. This variation may be due to differences in the collection time and area [27]. blaKPC gene was found in 4.4% of total isolates (2/45). This is in agreement with the result obtained by Haberecht et al. in Northern Colorado in which E. coli isolated from environmental water represented 4.2% of total suspected blaKPC [6]. Although studies reported the presence of blaSPM gene in E. coli isolated from water was limited, our result showed the prevalence of this gene is 8.8% in drinking water. But there was no significant correlation between the water source and blaSPM gene.

On the other hand, the isolates were negative for blaNDM, blaVIM, and blaIMP genes. The result is comparable to the study done by Petron et al. in Morocco, which found a similar finding among Serratia marcescens isolated from water specimens [28]. But this finding is in disagreement with a study conducted in the USA by Hoelle et al., which showed that about 55% of E. coli isolates were positive for VIM gene and 1% were positive for IMP gene [29]. These variations in the results may be explained by the differences in the time of study and their large sample size.

In the current study, we detected the carbapenemase gene in two bacterial species with phenotypical resistance to carbapenem drugs, but its resistance mechanisms were not detected by any of the screened carbapenemase primers used in this study. This might be due to the limited number of genes targeted in our study as well as to other mechanisms of resistance, such as porin loss/mutations [30].

Limitations of the present study include that a few samples were used and that did not represent a large population number. Also, the current research did not use primers to target all known carbapenemases genes. Despite these limitations, the study has provided the distribution of the common carbapenemase genes and the magnitude of the problem. Although the study did not investigate the clonality of the isolates and the sequence of the genes, tests based on molecular techniques are considered the standard tests for the identification of carbapenemase genes and multiplex-PCR as reliable, fast method for the detection of these genes [11].

5. Conclusion

There is a high frequency of E. coli harbored carbapenemase gene (blaOXA-48, blaSPM, and blaKPC) in drinking water in Khartoum State, Sudan. We found twenty-eight of E. coli isolates carried carbapenemase genes and tested as resistant to imipenem (13/45). blaOXA-48 (15.5) gene is the most predominant gene among positive isolates, followed by blaSPM (8.8) and blaKPC (4.4) genes. Resistance to tetracycline and chloramphenicol is also high, and it may be due to that the plasmid carries carbapenem-resistant genes, and it may carry other resistant genes. Also, it was found that there is no association ( value>0.05) with gentamicin, ceftriaxone, and ciprofloxacin antibiotics and the presence of carbapenem-resistant genes.

Further study using a large sample size is required to determine the prevalence of carbapenemase genes in drinking water. Although the investigation of clonality for the isolates and sequencing of the genes is important to be adequately characterized, the PCR technique provides a satisfied and reliable result for the detection of carbapenemase genes.

Data Availability

The data that support the descriptive statistical analyses of sample characteristics and resistance gene presence are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

The authors would like to thank Miss. Nafisa Osman, Faculty of Medical Laboratory Sciences, Al-Neelain University, for her great effort, guidance, and kind supervision. The authors also thank Mrs. OmimaAbdl El Jalil Adam for her help.

References

F. Adzitey, N. Sumaila, and C. K. S. Saba, “Isolation of E. coli from drinking water sources for humans and farm animals in Nyankpala community of Ghana,” Research Journal of Microbiology, vol. 10, no. 3, pp. 126–131, 2015.

R. Gomi, T. Matsuda, and M. Yoneda, “Whole-genome analysis of antimicrobialresistant and extraintestinal pathogenic Escherichia coli in river water,” Applied and Environmental Microbiology, vol. 83, 2017.

B. L. Coleman, “The role of drinking water as a source of transmission of antimicrobial resistant Escherichia coli,” Department of Public Health Sciences University of Toronto, Toronto, Canada, 2008.

H. Momtaz, F. S. Dehkordi, E. Rahimi, and A. Asgarifar, “Detection of Escherichia coli, Salmonella species, and Vibrio cholerae in tap water and bottled drinking water in Isfahan, Iran,” BMC Public Health, vol. 13, no. 1, 2013.

S. Ram, P. Vajpayee, and R. Shanker, “Prevalence of multi-antimicrobial-agent resistant, shiga toxin and enterotoxin producing Escherichia coli in surface waters of river ganga,” Environmental Science & Technology, vol. 41, no. 21, pp. 7383–7388, 2007.

H. B. Haberecht, N. J. Nealon, J. R. Gilliland et al., “Antimicrobial-resistant Escherichia coli from environmental waters in northern Colorado,” Journal of Environmental and Public Health, vol. 2019, Article ID 3862949, 13 pages, 2019.

K. Hamelin, G. Bruant, A. El-Shaarawi et al., “Occurrence of virulence and antimicrobial resistance genes in Escherichia coli isolates from different aquatic ecosystems within the St. clair river and detroit river areas,” Applied and Environmental Microbiology, vol. 73, no. 2, pp. 477–484, 2007.

B. Lyimo, J. Buza, M. Subbiah, W. Smith, and D. R. Call, “Comparison of antibiotic resistant Escherichia coli obtained from drinking water sources in northern Tanzania: a cross-sectional study,” BMC Microbiology, vol. 16, no. 1, p. 1, 2016.

P. K. Nair, “Prevalence of carbapenem resistant Enterobacteriaceae from a tertiary care hospital in Mumbai, India,” Journal of Microbiology and Infectious Diseases, vol. 03, no. 04, pp. 207–210, 2013.

G. Meletis, “Carbapenem resistance: overview of the problem and future perspectives,” Therapeutic Advances in Infectious Disease, vol. 3, no. 1, pp. 15–21, 2016.

S. B. Satir and A. I. Elkhalifa, “Detection of carbepenem resistance genes among selected gram negative bacteria isolated from patients in -Khartoum state, Sudan,” Clinical Microbiology: Open Access, vol. 5, no. 6, 2016.

T. Hong, E. Smith Moland, B. Abdalhamid et al., “Escherichia coli: development of carbapenem resistance during therapy,” Clinical Infectious Diseases, vol. 40, no. 10, pp. e84–e86, 2005.

S.-R. Huang, M.-F. Liu, C.-F. Lin, and Z.-Y. Shi, “Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections,” Journal of Microbiology, Immunology and Infection, vol. 47, no. 3, pp. 187–196, 2014.

P. Nordmann, T. Naas, and L. Poirel, “Global spread of carbapenemase-producingEnterobacteriaceae,” Emerging Infectious Diseases, vol. 17, no. 10, pp. 1791–1798, 2011.

R. I. Manenzhe, H. J. Zar, M. P. Nicol, and M. Kaba, “The spread of carbapenemase-producing bacteria in Africa: a systematic review,” Journal of Antimicrobial Chemotherapy, vol. 70, no. 1, pp. 23–40, 2015.

Z. Chen, D. Yu, S. He et al., “Prevalence of antibiotic-resistant Escherichia coli in drinking water sources in Hangzhou City,” Frontiers in Microbiology, vol. 8, 2017.

M. Cheesbrough, Medical Manual for Tropical Countries, vol. 2, University Press, Cambridge, UK, 1984.

WHO and W. Samplinganalysis, “Water sampling and analysis,” Analysis, vol. 19, pp. 51–72, 1997.

M. Ghavidel, H. SalariSedigh, and J. Razmyar, “Isolation of Clostridium difficile and molecular detection of binary and A/B toxins in faeces of dogs,” Iranian Journal of Veterinary Research, vol. 17, no. 4, pp. 273–276, 2016.

S. Shoja, M. Moosavian, A. Peymani, M. A. Tabatabaiefar, S. Rostami, and N. Ebrahimi, “Genotyping of carbapenem resistant Acinetobacter baumannii isolated from tracheal tube discharge of hospitalized patients in intensive care units, Ahvaz, Iran,” Iranian Journal of Microbiology, vol. 5, no. 4, pp. 315–322, 2013.

M. F. Mushi, S. E. Mshana, C. Imirzalioglu, and F. Bwanga, “Carbapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania,” BioMed Research International, vol. 2014, pp. 1–6, 2014.

M. Ylmaz, C. Ozic, and L Gok, “Principles of nucleic acid separation by agarose gel electrophoresis,” in Gel Electrophoresis Principles and Basics, InTech, London, UK, 2012.

IBM, SPSS Statistics for Windows, Version 21.0, IBM Corp, Armonk, NY, USA, 2012, http://www.ibm.com/software/analytics/spss/IBMCorp.

D. E. Harmon, O. A. Miranda, A. McCarley, M. Eshaghian, N. Carlson, and C. Ruiz, “Prevalence and characterization of carbapenem‐resistant bacteria in water bodies in the los angeles-southern california area,” MicrobiologyOpen, vol. 8, no. 4, p. e00692, 2019.

J. Hrenovic, G. Durn, S. Kazazic, S. Dekic, and M. S. Music, “Untreated wastewater as a source of carbapenem-resistant bacteria to the riverine ecosystem,” Water SA, vol. 45, 2019.

E. Amaya, D. Reyes, M. Paniagua et al., “Antibiotic resistance patterns of Escherichia coli isolates from different aquatic environmental sources in Leon, Nicaragua,” Clinical Microbiology and Infection, vol. 18, no. 9, pp. E347–E354, 2012.

W. D. Tanner, J. A. VanDerslice, and A. V. Gundlapalli, “Multi-state study of Enterobacteriaceae harboring extended-spectrum beta-lactamase and carbapenemase genes in U.S. drinking water,” Scientific Reports, vol. 9, 2019.

A. Potron, L. Poirel, and P. Nordmann, “Occurrence of the carbapenem-hydrolyzing β-lactamase gene bla OXA-48 in the environment in Morocco,” Antimicrobial Agents and Chemotherapy, vol. 5413-5414, 2011.

J. Hoelle, J. R. Johnson, B. D. Johnston et al., “Survey of US wastewater for carbapenem-resistant Enterobacteriaceae,” Journal of Water and Health, vol. 17, no. 2, pp. 219–226, 2019.

I. Rossi Gonçalves, R. C. C. Dantas, M. L. Ferreira, D. W. d. F. Batistão, P. P. Gontijo-Filho, and R. M. Ribas, “Carbapenem-resistant Pseudomonas aeruginosa: association with virulence genes and biofilm formation,” Brazilian Journal of Microbiology, vol. 48, no. 2, pp. 211–217, 2017.